All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

Aortic stenosis (AS) is characterised by a narrowing of the aortic valve opening, which induces a left ventricular (LV) pressure overload. The development of LV hypertrophy in AS is accompanied by coronary microcirculatory dysfunction \[[@pone.0229609.ref001]\] that may gradually affect systolic and diastolic function \[[@pone.0229609.ref002]\]. LV ejection fraction (LVEF) is used routinely to assess LV systolic function and is an important parameter for prognosis stratification \[[@pone.0229609.ref003]\]. However, LVEF depends not only upon the contractility of LV, but also on loading conditions. In fact, ejection fraction may appear to be preserved despite underlying reduced contractility The characterisation of myocardial dysfunction is of primary importance to identify patients with reduced contractility. Speckle-tracking echocardiography (STE) assessment of myocardial strain usually provides a better quantification of systolic function than global LVEF \[[@pone.0229609.ref004]\]. Although strain echocardiography can provide prognostic information in patients with AS \[[@pone.0229609.ref005]\], the shortening indices, calculated from cardiac strains, do not reflect myocardial work or oxygen demand. As opposed to the normal LV, where all segments contract almost synchronously and myocardial energy is used effectively, regional dysfunction, that could be induced by myocardial fibrosis \[[@pone.0229609.ref006]\], could bring a significant loss of efficient work. For instance, the impairment of myocardial diastolic and systolic function, due to fibrosis \[[@pone.0229609.ref007]\], have shown to induce significant mechanical dispersion in patients with severe AS \[[@pone.0229609.ref008]\].

Recently, Russell et al \[[@pone.0229609.ref009], [@pone.0229609.ref010]\] have proposed a non-invasive method for LV work analysis, which is based upon an estimated LV pressure curve. As strain is largely influenced by LV afterload \[[@pone.0229609.ref011]\], model-based myocardial work might be a robust complementary tool, taking into account AS severity and arterial pressures values. In previous works of our team, we have shown that the non-invasive estimation of global myocardial work, when using an LV pressure curve estimation as proposed in \[[@pone.0229609.ref009]\], is correlated with that obtained when using the observed invasive LV pressure curve, in the context of cardiac resynchronization therapy \[[@pone.0229609.ref012]\]. However, the accuracy of estimated LV pressure has never been evaluated in the case of aortic stenosis, where high pressure gradients could be observed between LV and the aorta \[[@pone.0229609.ref013]\]. The experimental observation of LV pressure is notably difficult to perform clinically because it requires an invasive, intraventricular measurement. As a consequence, it is necessary to propose novel tools to assess non-invasive LV pressure and to calculate myocardial work in the case of AS.

The first objective of this paper was to propose a model-based estimation of LV pressure in the case of AS. Previous works \[[@pone.0229609.ref014], [@pone.0229609.ref015]\] has already shown that lumped-parameter models of ventricular-vascular coupling are able to provide a good agreement between the estimated and the measured left ventricular and aortic pressure waveforms. Based on these papers and previous works of our team \[[@pone.0229609.ref016]--[@pone.0229609.ref018]\], we proposed a model-based approach, including a multiformalism model of the cardiovascular system and a parameters identification strategy using a Monte-Carlo cross-validation method, in order to: 1) estimate LV pressure waveform from experimental LV pressure curve, systolic and diastolic aortic pressure values, 2) assess LV pressure waveform from only systolic and diastolic aortic pressure values.

The second objective of the paper was to propose a novel tool to estimate myocardial work in AS. Work indices, as proposed in \[[@pone.0229609.ref009], [@pone.0229609.ref010]\] and validated in \[[@pone.0229609.ref012]\], were calculated from non-invasive model-based LV pressure and compared with indices evaluated from experimental signals. This article does not claim to validate the estimation of myocardial work in a cohort of AS patients but it aims to propose an original approach for the assessment of work indices based on computational modelling. The paper is organised as follows: in Section 2, the experimental protocol and data under study are presented, the computational model is described and the identification method is explained. In Section 3, the results of applying the described methods are presented and discussed. Discussions are finally specified in Section 4.

1 Materials and methods {#sec002}
=======================

1.1 Experimental data {#sec003}
---------------------

### 1.1.1 Study population {#sec004}

We prospectively included 12 adults (≥18 years old) with severe (aortic valve area (AVA) ≤ 1cm^2^, n = 11) and moderate (n = 1) aortic stenosis who underwent a coronary angiography with left heart catheterization. [Table 1](#pone.0229609.t001){ref-type="table"} summarizes patients' clinical characteristics. We excluded patients with concomitant significant aortic regurgitation and mitral stenosis. The study was carried out in accordance with the principles outlined in the Declaration of Helsinki on research in human subjects and received specific ethical approval from of the local Medical Ethics Committee (Person Protection Committee West V---CPP Ouest V, authorization number: 2014-A01331-456). All patients were informed and a written consent was obtained.
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###### Patients' clinical characteristics.

![](pone.0229609.t001){#pone.0229609.t001g}

  --------------------------------------------------------------------------------------
                          Age\           Male sex\   BSA\                  NYHA class\
                          *years old*    *n (%)*     (body surface area)   II/III, *n*
  ----------------------- -------------- ----------- --------------------- -------------
  **Patients (n = 12)**   78.16 ± 5.50   7 (58.3%)   1.75 ± 0.10           8/4

  --------------------------------------------------------------------------------------

### 1.1.2 Echocardiography {#sec005}

All patients underwent a standard Trans-Thoracic Echocardiography (TTE) using a Vivid S6, E7 or E9 ultrasound system (General Electric Healthcare, Horten, Norway). Images were recorded on a remote station for off-line analysis by dedicated software (EchoPAC PC, version BT 202, General Electric Healthcare, Horten, Norway). The analysis of aortic and mitral valve events during a complete TTE loop \[mitral valve closure (MVC), aortic valve opening (AVO), aortic valve closure (AVC), mitral valve opening (MVO)\] was performed in apical long-axis view and individual valvular events were manually segmented. Standard STE analysis was applied in order to extract regional myocardial strain curves. Also aortic stenosis analysis was performed to estimate the AVA (cm^2^).

### 1.1.3 Invasive experimental pressure {#sec006}

The left heart catheterization (LHC) was performed via a retrograde access from the radial artery with a 5 French Judkin R4 catheter (ICU Medical, San Clemente, CA, USA) placed at the mid LV cavity using fluoroscopic screening. Before coronary angiography, transducers were calibrated, with a 0-level set at the mid-axillary line. In a second time, catheter was placed in the thoracic ascendant aorta to measure aortic pressure. The experimental invasive data set includes the measured ventricular pressure $P_{LV}^{exp}$, the systolic $P_{ao,sys}^{exp}$ and diastolic $P_{ao,dias}^{exp}$ arterial pressures.

1.2 Computational model {#sec007}
-----------------------

Four main sub-models were created and coupled: *i)* cardiac electrical system, *ii)* elastance-based cardiac cavities, *iii)* systemic and pulmonary circulations and *iv)* heart valves. The first three submodels are strongly based on our previous works \[[@pone.0229609.ref016]--[@pone.0229609.ref021]\]. The model of the heart valves was adapted from \[[@pone.0229609.ref022]\].

### 1.2.1 Cardiac electrical system {#sec008}

The proposed model of the cardiac electrical activity, is based on a set of coupled automata \[[@pone.0229609.ref019], [@pone.0229609.ref020]\] ([Fig 1](#pone.0229609.g001){ref-type="fig"}). Each automaton represents the electrical activation state of a given myocardial tissue, covering the main electrophysiological activation periods: slow diastolic depolarisation (SDD), upstroke depolarization (UDP), absolute refractory (ARP) and relative refractory (RRP). Briefly, the state of the cellular automata cycles through these four stages, sending an output stimulation signal to neighboring cells when a given cell is activated (end of UDP phase).

![*Left panel*: State diagram of the cellular automata that represent nodal cells (yellow, botton) and myocardial cells (orange, top) and diagrams showing the correspondence of the automata's transition parameters with the myocardial action potential dynamics. *Right panel*: Closed-loop model of the cardiovascular system. E: elastance; R: resistance; P: pressure; V: volume; pul: pulmonary; sys: systemic; pv: pulmonary vein; pa: pulmonary artery; ao: aorta; sa: systemic artery; sv: systemic veins; vc: vena cava; LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle. In the middle, a representation of the cardiac electrical system. On the right, a representation of the heart valve model.](pone.0229609.g001){#pone.0229609.g001}

The whole simplified model consists of seven automata representing: the sinoatrial node (NSA), right and left atria (RA and LA), the atrioventricular node (NAV), upper bundle of His (UH) and both ventricles (RV and LV). The electrical activation of the automata is used to synthesize an electrocardiogram (ECG), from which the QRS peak was extracted to synchronize the experimental and simulated signals.

### 1.2.2 Elastance-based cardiac cavities {#sec009}

Although the literature offers a wide range of cardiovascular models, elastance-based models offer a good compromise between complexity and number of parameters \[[@pone.0229609.ref016]--[@pone.0229609.ref018], [@pone.0229609.ref023]\]. Ventricle pressures are represented by a combination of the end-systolic (*es*) and end-diastolic (*ed*) pressure-volume relationships \[[@pone.0229609.ref024]\]: $$\begin{array}{r}
{P_{es,lv}\left( V,t \right) = E_{es,lv}\left( V\left( t \right) - V_{d,lv} \right),} \\
\end{array}$$ $$\begin{array}{r}
{\mspace{600mu}\mspace{600mu} P_{ed,lv}\left( V,t \right) = P_{0,lv}\left( e^{\lambda_{lv}{(V{(t)} - V_{0,lv})}} - 1 \right)\,} \\
\end{array}$$

In [Eq 1](#pone.0229609.e004){ref-type="disp-formula"}, systolic pressure *P*~*es*,*lv*~ is defined as a linear relationship with the ventricular volume *V*, determined by the systolic elastance *E*~*es*,*lv*~ and the volume intercept *V*~*d*,*lv*~. [Eq 2](#pone.0229609.e005){ref-type="disp-formula"} also describes the nonlinear diastolic pressure defined by a gradient *P*~0,*lv*~, curvature λ~*lv*~ and volume intercept *V*~0,*lv*~. The instantaneous pressure of the ventricle is then calculated as: $$\begin{array}{r}
{P_{lv}\left( V,t \right) = e_{lv}\left( t \right)P_{es,lv}\left( V,t \right) + \left( 1 - e_{lv}\left( t \right) \right)P_{ed,lv}\left( V,t \right)} \\
\end{array}$$ where *e*~*lv*~(*t*) is the driver function that controls time-variant elastance. In this work we have selected a "double Hill" driver function \[[@pone.0229609.ref025]\] that best fits our observed data: $$\begin{array}{r}
{e_{lv}\left( t \right) = k \cdot \left\lbrack \frac{\left( \frac{t}{\alpha_{1}T} \right)^{n_{1}}}{1 + \left( \frac{t}{\alpha_{1}T} \right)^{n_{1}}} \right\rbrack \cdot \left\lbrack \frac{1}{1 + \left( \frac{t}{\alpha_{2}T} \right)^{n_{2}}} \right\rbrack\,} \\
\end{array}$$

The first and second terms in [Eq 4](#pone.0229609.e007){ref-type="disp-formula"} represent ventricle contraction and relaxation, respectively. *k* is a scaling factor that defines the maximal value of elastance, *T* is the heart period, *α*~1~, *α*~2~ are shape parameters, and *n*~1~,*n*~2~ control the steepness of the curve.

To account for the mechanical function of the atria, the atrial pressure *P*~*la*~ is represented as a linear function of its instantaneous volume *V*~*la*~, whose slope *E*~*la*~ represents the elastic properties of the atrial wall: $$\begin{array}{r}
{P_{la}\left( V_{a},t \right) = E_{la}\left( t \right) \cdot \left( V_{la}\left( t \right) - V_{d,la} \right),} \\
\end{array}$$ $$\begin{array}{r}
{E_{la}\left( t \right) = E_{la,max}\left( e_{la}\left( t \right) + \frac{E_{la,min}}{E_{la,max}} \right)\,} \\
\end{array}$$ where *e*~*la*~(*t*) is a Gaussian driving function that cycles between atrial diastole and systole: $$\begin{array}{r}
{e_{la}\left( t \right) = \text{exp}\left( - B_{la} \cdot \left( t - C_{la} \right)^{2} \right)\,} \\
\end{array}$$

Using *B*~*la*~ and *C*~*la*~, it is possible to control the rise and peak of the atrial systole.

### 1.2.3 Systemic and pulmonary circulations {#sec010}

Concerning the circulatory models \[[@pone.0229609.ref021]\], the volume change of each cardiac or vessel chamber is calculated from the net flow: Δ*V*(*t*) = ∫(*Q*~*in*~ − *Q*~*out*~)d*t*. The flows are defined by the pressure gradient across chambers and a resistance: $Q = \frac{\Delta P}{R}$. The pressure of arterial and venous vessels are defined as an elastance dependent linear relationship, similar to [Eq 1](#pone.0229609.e004){ref-type="disp-formula"}. The circulatory model allows for the simulation of systolic and diastolic aortic pressures ($P_{ao,sys}^{model}$ and $P_{ao,dias}^{model}$).

### 1.2.4 Cardiac valves {#sec011}

The cardiovascular system (CVS) model was coupled to a detailed representation of the heart valves dynamics (mitral, aortic, tricuspid and pulmonary) according to \[[@pone.0229609.ref022]\]. The relation between the pressure gradient (Δ*P*) and the fluid flow (*Q*) across an open valve is approximated by the Bernoulli equation ([Eq 8](#pone.0229609.e014){ref-type="disp-formula"}): $$\begin{array}{r}
{\Delta P = \left. BQ \middle| Q \right| + L\frac{dQ}{dt},} \\
\end{array}$$ $$\begin{array}{r}
{B = \frac{\rho}{2A_{eff}^{2}},\mspace{600mu} L = \frac{\rho l_{eff}}{A_{eff}}} \\
\end{array}$$ where *B* and *L* are respectively the Bernoulli resistance and the blood inertance. Parameter *ρ* stands for the blood density, *A*~*eff*~ is the effective cross-sectional area of the valve ([Eq 10](#pone.0229609.e016){ref-type="disp-formula"}) and *l*~*eff*~ is the effective length of the valve: $$\begin{array}{r}
{A_{eff}\left( t \right) = \left\lbrack A_{eff,max}\left( t \right) - A_{eff,min}\left( t \right) \right\rbrack\xi\left( t \right) + A_{eff,min}\left( t \right)} \\
\end{array}$$ $$\begin{array}{r}
{\frac{d\xi}{dt} = \left\{ \begin{aligned}
{\left( 1 - \xi \right)K_{vo}\Delta P,} & {{if}\Delta P > 0} \\
{\xi K_{vc}\Delta P,} & {{if}\Delta P \leq 0} \\
\end{aligned}\operatorname{} \right.} \\
\end{array}$$

*A*~*eff*,*max*~ and *A*~*eff*,*min*~ are the maximum and minimum effective areas. The rate of opening *ξ*(*t*) describes the dynamic of the valve position ([Eq 11](#pone.0229609.e017){ref-type="disp-formula"}), in response to Δ*P*. *K*~*vo*~ and *K*~*vc*~ are the rate coefficients for valve opening and closure, respectively.

1.3 Estimation of myocardial work {#sec012}
---------------------------------

Segmental myocardial work, as proposed by Russell et al \[[@pone.0229609.ref010]\], could be calculated from 1) the clinical strain signals, deduced from TTE, and 2) the LV pressure obtained invasively by catheterization ($P_{LV}^{exp}$) or the patient-specific pressure ($P_{LV}^{model}$) from the model-based approach. The instantaneous power was first obtained by multiplying the strain rate, obtained by differentiating the strain curve, and the instantaneous LV pressure. Then, segmental myocardial work was calculated by integrating the power over time, during the cardiac cycle from mitral valve closure until mitral valve opening.

Positive and negative work \[[@pone.0229609.ref012]\] were determined as the ascending and descending parts of the curves ([Fig 2](#pone.0229609.g002){ref-type="fig"}), during isovolumic contraction and ejection (*S* phase) and isovolumic relaxation (*IVR* phase). Then, positive segmental work *W*~*p*~ (respectively *W*~*n*~) is defined as the sum of positive (respectively negative) variations for each segment *k* and for each phase (*S* and *IVR*): $$\begin{array}{r}
{W_{p,k}^{S} = \sum\limits_{i}P_{i,k}^{S},\mspace{720mu} W_{n,k}^{S} = \sum\limits_{j}N_{j,k}^{S},} \\
\end{array}$$ $$\begin{array}{r}
{W_{p,k}^{IVR} = \sum\limits_{i}P_{i,k}^{IVR},\mspace{720mu} W_{n,k}^{IVR} = \sum\limits_{j}N_{j,k}^{IVR}} \\
\end{array}$$ where *P*~*i*~ (respectively *N*~*j*~) is the variation associated with each ascending (respectively descending) parts *i* (respectively *j*) of the segmental work ([Fig 2](#pone.0229609.g002){ref-type="fig"}). The indices *i* (respectively *j*) are comprised between 1 and the total number of ascending (respectively descending) parts. Finally, global constructive (*GCW*) and wasted (*GWW*) work are defined as mean values over all segments: $$\begin{array}{r}
{GCW = \frac{1}{k}\sum\limits_{k = 1}^{K}\left( W_{p,k}^{S} + W_{n,k}^{IVR} \right),} \\
\end{array}$$ $$\begin{array}{r}
{GWW = \frac{1}{k}\sum\limits_{k = 1}^{K}\left( W_{n,k}^{S} + W_{p,k}^{IVR} \right)} \\
\end{array}$$ where *K* is the total number of segments. *GCW* represents segmental shortening during the systole, i.e. effective energy for blood ejection, and lengthening during *IVR*, whereas *GWW* corresponds to segmental stretching during the systole, i.e. energy loss for blood ejection and shortening during the isovolumic relaxation phase. GWE is defined as the global work efficiency: $$\begin{array}{r}
{GWE = \frac{GCW}{GCW + GWW}} \\
\end{array}$$

![Calculation of positive and negative segmental work.\
Positive (*P*~*j*~) and negative (*N*~*i*~) work are marked respectively as red and black. Phase *S* corresponds to isovolumic contraction and ejection. *IVR* is the isovolumic relaxation. S phase is defined by the time interval spanning from MVC to AVC, whereas the IVR phase is defined between AVC and MVO.](pone.0229609.g002){#pone.0229609.g002}

1.4 Model-based, patient-specific LV pressure estimation {#sec013}
--------------------------------------------------------

### 1.4.1 Sensitivity analysis {#sec014}

The objective of the sensitivity analysis is to determine the sets of ventricular {**X**~*LV*~} and circulatory {**X**~*art*~} parameters that have the most important influence on the gradient of pressure ($\Delta P^{model} = max\left( P_{LV}^{model} \right) - P_{ao,sys}^{model}$) between LV and aorta. Using the Morris elementary effects method \[[@pone.0229609.ref026]\], the sensitivity of each parameter is estimated by repeated measurements of a simulation output *Y* with parameters **X**, while changing one parameter *X*~*j*~ at a time. The method consists in the generation of several random trajectories through the parameter space; each trajectory being associated with an estimation of the Elementary Effects $EE_{j}^{*}$ of a parameter *X*~*j*~ on output *Y*: $$\begin{array}{r}
{\left. {EE}_{j}^{*} = \middle| \frac{Y\left( X_{1},\ldots,X_{j},\ldots \right) - Y\left( X_{1},\ldots,X_{j} + \Delta,\ldots \right)}{\Delta} \right|\,} \\
\end{array}$$ where Δ is a predefined variation. For each *X*~*j*~, the mean $\mu_{j}^{*}$ and standard deviation *σ*~*j*~ of *r* elementary effects (*EE*~*j*~) are calculated. A large value of $\mu_{j}^{*}$ indicates a significant effect of *X*~*i*~ on *Y*, whereas a large *σ*~*j*~ value is related to either non-linear or strongly interacting variables. In order to establish a global rank of importance among parameters, we calculated the Euclidean distance *D*~*j*~ in the *μ*\* − *σ* plane, from the origin to each ($\mu_{j}^{*}$, *σ*~*j*~) point: $$\begin{array}{r}
{D_{j} = \sqrt{\left( \mu_{j}^{*} \right)^{2} + \sigma_{j}^{2}}} \\
\end{array}$$ being parameters with high sensitivity or strong interactions those presenting the highest values for *D*~*j*~. Analysis were performed with *Y* = Δ*P*^*model*^ and, for each parameter *X*~*j*~, the range of possible values was defined as ±30% of the initial values ([S1 File](#pone.0229609.s003){ref-type="supplementary-material"}).

### 1.4.2 Parameter identification {#sec015}

The parameter identification process is included into a Monte-Carlo cross-validation approach ([Fig 3](#pone.0229609.g003){ref-type="fig"}). For all patients, the maximum effective area *A*~*eff*,*max*~ parameter was fixed to the observed AVA, measured from TTE. Available data from the 12 patients were divided randomly into two sets of 6 patients (training and test sets). This random selection process was applied *N* times (*n* ⩽ *N*) and for each realization *n* a two-step procedure was applied. The following sections provide more details on these steps.

![Two steps of the identification process.\
Step 1 consists in the minimization of *J*~*step*1~ for the identification of {**X**~*LV*~, **X**~*art*~} from invasive LV pressure and non-invasive arterial pressure. Step 2 consists in the minimization of *J*~*step*2~ for the identification of {**X**~*art*~} from non-invasive arterial pressure. Finally, $P_{LV}^{model}$ is estimated for each patient from ${\overline{\mathbf{X}}}_{LV}^{*}$ and $\mathbf{X}_{art}^{*}$.](pone.0229609.g003){#pone.0229609.g003}

**Step 1**: For each training patient, a parameter identification stage was implemented to find the best set of parameters $\left\{ \mathbf{X}_{LV}^{*},\mathbf{X}_{art}^{*} \right\}$ that minimises the error function between simulation outputs and experimental signals: $$\begin{array}{r}
{J_{step1} = J_{PLV} + J_{Pao,sys} + J_{Pao,dias}} \\
\end{array}$$ *J*~*Pao*,*sys*~, *J*~*Pao*,*dias*~ and *J*~*PLV*~ could be defined as: $$\begin{array}{r}
{J_{Pao,sys} = \mid P_{ao,sys}^{exp} - P_{ao,sys}^{model} \mid ,} \\
\end{array}$$ $$\begin{array}{r}
{J_{Pao,dias} = \mid P_{ao,dias}^{exp} - P_{ao,dias}^{model} \mid ,} \\
\end{array}$$ $$\begin{array}{r}
{J_{PLV} = \frac{1}{T_{c}}\sum\limits_{t_{e} = 0}^{T_{c} - 1} \mid P_{LV}^{exp}\left( t_{e} \right) - P_{LV}^{model}\left( t_{e} \right) \mid} \\
\end{array}$$ where *t*~*e*~ corresponds to the time elapsed since the onset of the identification period and *T*~*c*~ is the duration of a cardiac cycle. The error function *J*~*step*1~ was minimised using evolutionary algorithms (EA). These stochastic search methods are founded on theories of natural evolution, such as selection, crossover and mutation \[[@pone.0229609.ref027]\]. After this identification step, ventricular parameters were fixed equal to the average values over all the training patients (${\overline{\mathbf{X}}}_{LV}^{*}$ = mean($\mathbf{X}_{LV}^{*}$)).

**Step 2**: For each test patient, only circulatory parameters {**X**~*art*~} were identified by minimising the error function: $$\begin{array}{r}
{J_{step2} = J_{Pao,sys} + J_{Pao,dias}} \\
\end{array}$$ From the best set of parameters $\left\{ \mathbf{X}_{art}^{*} \right\}$, LV pressure $P_{LV}^{model,i}$ was simulated for each test patient and for each iteration *i* of the 2-step identification algorithm. Then, *GCW*^*model*,*i*^ and *GWW*^*model*,*i*^ were calculated from $P_{LV}^{model,i}$ of each patient. Therefore, at the end of the *N* iterations, a set of *i* simulated pressure and work indices was generated for each patient and averaged markers were determined: *GCW*^*model*^ = $\overline{GCW^{model,i}}$, *GCW*^*model*^ = $\overline{GCW^{model,i}}$ and *GWE*^*model*^ = $\overline{GWE^{model,i}}$.

1.5 Comparison between simulations and experimental data {#sec016}
--------------------------------------------------------

### 1.5.1 Comparison of estimated and measured pressures {#sec017}

Inspired form \[[@pone.0229609.ref014]\], estimated $P_{LV}^{model}$, $P_{ao,sys}^{model}$ and $P_{ao,dias}^{model}$ were compared with measured pressures by calculating the total relative error defined as: $$\begin{array}{r}
{e_{\%} = 50\left( \frac{\parallel P_{LV}^{exp} - P_{LV}^{model} \parallel}{\parallel P_{LV}^{exp} \parallel} \right) + 50\left( \frac{\mid P_{ao,sys}^{exp} - P_{ao,sys}^{model} \mid}{\mid P_{ao,sys}^{exp} \mid} + \frac{\mid P_{ao,dias}^{exp} - P_{ao,dias}^{model} \mid}{\mid P_{ao,dias}^{exp} \mid} \right)} \\
\end{array}$$ where ∥.∥ stands for the vectorial 1-norm. A linear regression was performed on all the points from experimental and simulated pressure waveforms. The slope (*β*) and coefficient of determination (*R*^2^) were deduced from the linear regression.

### 1.5.2 Comparison of estimated and measured work indices {#sec018}

In this paper, *GCW*, *GWW*, and *GWE* were calculated in two different manners: 1) *GCW*^*exp*^, *GWW*^*exp*^ and *GWE*^*exp*^ using the invasive experimental pressure $P_{LV}^{exp}$, and 2) *GCW*^*model*^, *GWW*^*model*^ and *GWE*^*model*^ using the proposed patient-specific pressure $P_{LV}^{model}$ from the model-based approach. The goodness of work estimations was evaluated by performing a linear regression using indices calculated from invasive experimental and the proposed model-based pressures. Bland-altman (BA) plots were also presented for the three work indices.

2 Results {#sec019}
=========

2.1 Hemodynamic simulations {#sec020}
---------------------------

[Fig 4](#pone.0229609.g004){ref-type="fig"} illustrates the hemodynamic simulation results of the proposed computational model; the LV and aortic pressures in healthy and AS subjects. Concerning the healthy subject, systolic LV pressure is equal to 120 mmHg, and the aortic pressure varies between 50 and 120 mmHg. AS was represented as a decrease in the *A*~*eff*,*max*~ parameter (from 2.5 to 0.75 *cm*^2^). In [Fig 4](#pone.0229609.g004){ref-type="fig"}, it is observed an important gradient pressure between LV (0-150 mmHg) and aorta (50-110 mmHg), characteristic of an AS, in which the narrowing of the aortic valve opening evokes an LV pressure overload.

![Example simulated LV and arterial pressure for a healthy (top) and an aortic stenosis subject (bottom).](pone.0229609.g004){#pone.0229609.g004}

2.2 Sensitivity analysis {#sec021}
------------------------

Sensitivity results evaluated on the gradient of systolic pressure between LV and aorta (Δ*P*^*model*^), are presented in [Fig 5](#pone.0229609.g005){ref-type="fig"}, only showing those parameters having the highest sensitivities. [Fig 5](#pone.0229609.g005){ref-type="fig"} shows the 25 most relevant parameters based on their *D*~*j*~ index; *μ*~*j*~\* and *σ* are also represented. The most influential parameter corresponds to the effective area of the aortic valve (*A*~*eff*,*max*~). In fact, a decrease of the effective area causes an increase in the ventricular systolic pressure, and consequently, on the gradient of systolic pressure between LV and aorta. Parameters related to the elastance of the LV (*E*~*es*,*lv*~ and *α*~2~) have also a high sensitivity on the gradient of systolic pressures. *E*~*es*,*lv*~ corresponds to the maximum LV elastance and is related to myocardial contractility. *α*~2~ represents the shape parameter related to the LV relaxation phase.

![Most influential parameters on the gradient of systolic pressure between LV and aorta according to Morris sensitivity results.\
For each parameter, the distance *D*~*i*~ (green bars), the absolute mean *μ*~*i*~\* (purple bars) and the standard deviation *σ* (yellow bars) of the elementary effects are represented.](pone.0229609.g005){#pone.0229609.g005}

*A*~*eff*,*max*~ presents the highest sensitivity. Fortunately, this parameter can be non-invasively observed and has been fixed to the AVA value measured from TTE specifically to each patient. The ventricular and circulatory parameters with the highest sensitivities were selected for ventricular and circulatory parameter estimations: **X**~*LV*~ = {*E*~*es*,*lv*~, λ~*lv*~, *P*~0,*lv*~, *α*~1~, *α*~2~, *n*~1~, *n*~2~} and **X**~*art*~ = {*E*~*ao*~, *E*~*vc*~, *E*~*sa*~, *E*~*sv*~, *Vd*~*ao*~, *Vd*~*vc*~, *Vd*~*sa*~, *Vd*~*sv*~, *R*~*ao*~, *R*~*sys*~, *R*~*vc*~}.

Except for {**X**~*LV*~, **X**~*art*~}, model parameter values were selected from the publications from which each model was originally based on: ventricular and circulatory parameters were taken from \[[@pone.0229609.ref016]--[@pone.0229609.ref018], [@pone.0229609.ref023]\], heart valve parameters were adapted from \[[@pone.0229609.ref022]\], and cardiac electrical conduction system from \[[@pone.0229609.ref019]\].

2.3 Patient-specific model-based pressure {#sec022}
-----------------------------------------

### 2.3.1 Step 1: Estimation of LV pressure from invasive data {#sec023}

Concerning step 1 of the parameter identification, there was a good agreement between estimated and measured pressure waveforms ([Fig 6](#pone.0229609.g006){ref-type="fig"}). Mean *R*^2^ was equal to 0.96 (min: 0.91, max: 0.99). Mean slope and intercept of the regression line between the simulated and the measured pressure data were 1.04 (95% confidence interval: 1.0, 1.09) and -8.48 (-8.52, -8.44) mmHg respectively. Mean total relative error was equal to 11.9% and ranged from 6.4% to 17.3%.

![LV pressure of the 12 AS patients from step 1: i) experimental (black) and ii) simulated curve (red) curves.](pone.0229609.g006){#pone.0229609.g006}

### 2.3.2 Step 2: Estimation of LV pressure from systolic and diastolic pressure values {#sec024}

Concerning step 2 of the parameter identification, LV pressure waveforms ([Fig 7](#pone.0229609.g007){ref-type="fig"}) are only estimated from systolic and diastolic pressure values and *A*~*eff*,*max*~ has been fixed to the AVA value measured from TTE specifically to each patient. Slope and intercept of the regression line were 1.03 (0.92, 1.14) and---7.74 (-7.63, -7.85) mmHg respectively, and mean *R*^2^ was 0.91. Total relative error ranged between 5.9% and 17.40% and average value is 12.27%.

![LV pressure of the 12 AS patients from step 2: i) experimental curve (black), ii) average and standard deviation of simulated curve (red).](pone.0229609.g007){#pone.0229609.g007}

2.4 Comparison of global cardiac work indices {#sec025}
---------------------------------------------

[Fig 8](#pone.0229609.g008){ref-type="fig"} presents scatter and BA plots for GCW, GWW and GWE indices. Correlations between measures and model-based estimations were respectively 0.88 (p \< 0.0001) and 0.80 (p \< 0.003) for GCW and GWW. When considering both constructive and wasted work indices, global correlation was equal to 0.96 (p \< 0.0001). In BA analysis, mean bias were -140 mmHg.% and -12 mmHg.% respectively for GCW and GWW, which correspond to relative bias equal to 3.47% and 2.93% with respect to maximum GCW and GWW values. For global work efficiency, correlation was 0.91(p \< 0.0001) and mean bias was equal to 0. For GWE, one patient is outside the 95% limits of agreement and corresponds to the third patient of the first row on [Fig 6](#pone.0229609.g006){ref-type="fig"} and [7](#pone.0229609.g007){ref-type="fig"}. For this patient, the synchronisation, between peaks of simulated and experimental pressures, is less good, showing the importance of time corresponding to peak pressure for work evaluation.

![Results of global work indices comparison, on all patients.\
Scatter plots and Bland---Altman analysis of: a) Global Constructive Work (GCW), b) Global Wasted Work (GWW) and c) Global Work Efficiency (GWE).](pone.0229609.g008){#pone.0229609.g008}

3 Discussion {#sec026}
============

In this paper, a patient-specific model-based estimation method was proposed in order to evaluate constructive, wasted myocardial work and global work efficiency on patients diagnosed with aortic stenosis. The main contributions of this study concern: *i)* the proposition of an integrated model of cardiovascular system model, *ii)* the analysis of this cardiovascular model in order to select the most sensitive parameters to be identified in a patient-specific manner, *iii)* a parameter identification approach able to reproduce LV pressure specifically to each patient and *iv)* the experimental validation of the proposed method through a cross-validation technique applied on 12 AS patients, in order to quantitatively evaluate GCW, GWW and GWE indices.

The heart valve model, proposed by \[[@pone.0229609.ref022]\], was coupled to a CVS model that includes representations of cardiac electrical activity, cardiac cavities and the circulation, developed by our group \[[@pone.0229609.ref016]--[@pone.0229609.ref021]\]. The integrated model is able to predict the influence of valve motion on hemodynamics in both normal and stenosis cases. The sensitivity analysis, performed on the integrated model, highlights the importance of effective area of the aortic valve and parameters related with LV elastance on the pressure gradient between LV and aorta. In fact, modifications of valve effective area, observed in stenosis, lead to an increased aortic resistance and to an elevated pressure gradient across the valve \[[@pone.0229609.ref013]\]. When the blood flows through a narrowed aortic valve, the hemodynamic conditions could also lead to modifications of ventricular elastance \[[@pone.0229609.ref028]\].

The most influential LV and aortic parameters found after sensitivity analysis were then identified for each one of the 12 patients. One of the main originality of the approach was to apply a Monte-Carlo cross-validation approach for the patient-specific estimations of LV pressures. In order to build the cost function, experimental and simulated pressures were synchronised on QRS peaks of synthesized and experimental ECG. In the first step of the identification process, model parameters were identified from invasive measured LV pressures, as well as systolic and diastolic arterial pressure values. Results show a good agreement between estimated and measured pressure waveforms. Concerning the second step of the identification, only systolic, diastolic arterial pressure values and AVA echocardiography estimations were used to identify some model parameters and to estimate LV pressure waveform. Although errors slightly increase compared to step 1, the approach has the advantage of using only non-invasive data for the estimation of LV pressure waveforms.

As shown in previous work of our team \[[@pone.0229609.ref012]\], although LV pressure is imprecise, the estimation of LV work could be accurate. In fact, even errors between model-based and measured pressures are around 12%, mean relative bias in BA analysis were 3.47%, 2.93% and 0.0% respectively for GCW, GWW and GWE. The consistency of LV work estimation could be explained by: i) the temporal integration, which induces a smoothing of the difference between measured and estimated works and ii) relative precision of the estimation of the pressure between AVO and AVC. Although the estimation of the LV pressure is imperfect, the non-invasive estimation of global myocardial work indices obtained from modelling approach strongly correlates with invasive measurements and the proposed estimation of LV myocardial work appears as clinically relevant.

Myocardial work indices are novel tools that have been validated in a variety of pathologies, including the response to cardiac resynchronization therapy (CRT) \[[@pone.0229609.ref029]\]. In particular, Russell et al. have shown that regional differences in myocardial work have a strong correlation with regional myocardial glucose metabolism, as evaluated using PET imaging \[[@pone.0229609.ref009]\]. However, the assessment of constructive and wasted work, in the case of AS is difficult because the estimation of peak LV pressure is complicated without any invasive measurement. To our knowledge, this paper presents the first method for the estimation of myocardial work, based on a physiological model, rather than a template-based estimate, such as in \[[@pone.0229609.ref009]\]. In this case, the model-based method allows for the integration of physiological knowledge in the evaluation of myocardial work indices. *In* *silico* assessment of clinical parameters, specifically to each patient, has the advantage of taking into account characteristics associated with the subject and pathology. For instance, by integrating a representation of the pathophysiology of the aortic valves within this physiological model, it becomes adapted to the case of aortic stenosis.

Results show globally a good agreement between work index estimations from LV pressure obtained with patient-specific simulations and with experimental measurements. The evaluation of cardiac work, in the case of AS, is promising because it could be a simple and physiological alternative to more complex and costly investigations (cardiac MRI,‥) for the evaluation of myocardial contractility and residual myocardial viability \[[@pone.0229609.ref030]\]. The assessment of regional myocardial work might be particularly important for the prognosis of patients with severe asymptomatic AS without LV dysfunction. In fact, the timing and indications for surgical intervention in this population remain controversial as the aortic-valve replacement is not recommended despite in the increased risk of cardiovascular mortality \[[@pone.0229609.ref031]\]. Indeed, as LVEF remains imperfect in asymptomatic AS to determine the optimal delay for the surgery, global longitudinal strain appears to have a better prognostic significance \[[@pone.0229609.ref032]\] and we can suppose that myocardial work will be a robust complementary index independent of afterload condition. In fact, because afterload data are included in the calculation of myocardial work in the form of LV pressure, the assessment of myocardial work might represent a more robust parameter with respect to the assessment of LV strain or other strain-derived parameters \[[@pone.0229609.ref033]\]. Although it will be important to confirm these assumptions and to validate the approach in a cohort of AS patients, this paper is a first essential step for the proposition of work estimation based on computational modelling. The proposed methodology should be evaluated on a larger prospective clinical database in the future and we believe that model-based work indices, especially GWE, could be promising to improve the assessment of LV mechanical efficiency in AS.

One limitation of this work concerns the number of patients included in this study. Although it appears to be low, it is necessary to recognise that measurement of invasive LV pressure is particularly difficult in AS. In fact, current guidelines discourage catheterization measurement techniques in AS before aortic valve replacement \[[@pone.0229609.ref034]\]. In this case, catheterization was realised for clinical reasons and all patients were informed. Another limitation is related to the estimation of LV filling pressure, which is not precisely estimated in step 2. In fact, myocardial work is considered in the period from mitral valve closure to mitral valve opening, so inaccuracies before mitral valve closure and after mitral valve opening has no impact on the results \[[@pone.0229609.ref012]\].

4 Conclusion {#sec027}
============

In this work, we propose an original model-based approach to assess constructive and wasted work in AS patients. The global method is based on a novel approach introducing: *i)* a physiological model of the cardiovascular system, including heart valves and *ii)* a 2-step identification procedure, based on a monte-carlo cross-validation method. The proposed model-based approach was evaluated with data from 12 AS patients for which LV pressure data was acquired invasively. Results show a close match between experimental and simulated LV and aortic pressures. The model-based approach is especially efficient for the evaluation of LV pressure from non-invasive data (systolic, diastolic pressures and aortic valve area). Moreover, estimations of constructive, wasted work and global work efficiency were consistent with indices calculated from measured experimental pressures, showing the model ability to produce realistic LV pressure for the calculation of work indices.

More extensive evaluations including a greater population of patients, as well as the analysis on a prospective study should be performed in the future. Furthermore, the proposed model could be enriched by including a regional description of myocardium \[[@pone.0229609.ref020]\]. Nevertheless, this paper presents the first model-based approach towards the evaluation of myocardial work indices in AS patients and, thus, provide a step forward the characterisation of the complex LV mechanics of patients with AS.
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27 Dec 2019

Reviewer \#1:

In this paper, Owashi et al. performed a model-based estimation of LV pressure and myocardial work that can be applied in the context of patients with aortic stenosis (AS). They validated their model in a cohort of 12 patients with AS (11 severe and 1 moderate AS). Authors reported model errors around 12% for the estimation of LV pressure.

I have few comments for the authors regarding the present manuscript.

1 -- Authors reported a good correlation between estimated and measured pressure (end of page 10). However, even if the correlation coefficient was relatively high (\>0.90), the intercept of the slope pointed out an underestimation ranged between 8 to 9 mmHg. Similar findings are identified in the second step of the analysis. Was this difference between model-based estimation and measured pressure clinically relevant? What was the clinical significance of this "systematic" underestimation? How can we ascertain the low clinical impact of this kind of LV pressure underestimation, especially in a context of AS?

We thank reviewer 1 for this interesting question. As shown in previous work of our team (Hubert 2018), although LV pressure is imprecise, the estimation of LV work could be accurate. In fact, even errors between model-based and measured pressures are around 12%, mean bias in BA analysis were -140 mmHg.% and -12 mmHg.% respectively for GCW and GWW, which correspond to relative bias equal to 3.47 % and 2.93 % with respect to maximum GCW and GWW. Mean bias for GWE is equal to 0. The consistency of LV work estimation could be explained by: i) the temporal integration, which induces a smoothing of the difference between measured and estimated works and ii) relative precision of the estimation of the pressure between AVO and AVC. Although the estimation of the LV pressure is imperfect, the non-invasive estimation of global myocardial work indices obtained from modelling approach strongly correlates with invasive measurements and we believe that the proposed estimation of LV myocardial work is clinically relevant. Discussion section was modified in order to better consider these aspects.

Hubert A et al. Estimation of myocardial work from pressure-strain loops analysis: an experimental evaluation. Eur Heart J Cardiovasc Imaging. 2018;doi:doi: 10.1093/ehjci/jey024.

2 -- Could you validate your estimation of myocardial work based on clinical gold standard currently used in clinic?

The gold standard consists in measuring invasively left ventricular myocardial deformation by sonomicrometry simultaneously with left ventricular pressure by micromanometer. In our study, LV pressure was measured because of clinically utility but it would be not ethical to realize sonomicrometry in patients with aortic stenosis for an observational study. Unfortunately, this gold standard is impossible in human, only in animals, as Urheim et al (2005) did for normal LV.

Urheim S et al. Regional myocardial work by strain Doppler echocardiography and LV pressure: a new method for quantifying myocardial function. American Journal of Physiology - Heart and Circulatory Physiology. 2005;288:H2375--H2380.

3 -- What is the additive value of the estimation of myocardial pressure or work as compared to echo based data including AVA and LV function parameters? A validation of the clinical impact of this approach will considerably strengthen the paper.

Timing and indications for surgical intervention in patients with severe asymptomatic AS without LV dysfunction remains highly controversial. In fact, surgery is currently not recommended despite in the increased risk of cardiovascular mortality in this population (Kang DH et al., 2019). Global longitudinal strain appears to have a better significance than left ventricular ejection fraction to predict events in this population (Magne J et al., 2019). But it's well known that GLS is afterload dependant so our hypothesis is that myocardial work, taking in count LV afterload, will better stratify pre-operative and post-operative risk in this population. In fact, because afterload data are included in the calculation of myocardial work in the form of LV pressure, the assessment of myocardial work might represent a more robust parameter with respect to the assessment of LV strain or other strain-derived parameters.

Discussion was modified in order the better describe the clinical objectives of this approach.

Kang DH et al. Early surgery or conservative care for asymptomatic aortic stenosis. NEJM 2019, DOI: 10.1056/NEJMoa1912846

Magne J et al. Distribution and Prognostic Significance of Left Ventricular Global Longitudinal Strain in Asymptomatic Significant Aortic Stenosis: An Individual Participant Data Meta-Analysis. JACC Cardiovasc Imaging. 2019;12:84--92

Galli, E, Leclercq, C, Fournet, M, Hubert, A, Bernard, A, Smiseth, OA, Mabo, P, Samset, E, Hernandez, A, Donal, E (2018). Value of Myocardial Work Estimation in the Prediction of Response to Cardiac Resynchronization Therapy. J Am Soc Echocardiogr, 31, 2:220-230.

4 -- What is the efficacy of the model in patients with a more advance stage of the LV dysfunction?

For this first approach of the model, we decided to have a homogeneous population so aortic stenosis with normal ejection fraction. But this question is very interesting and should be adressed in further studies.

5 -- Authors provided echo data for each patient in a supplemental table. The LVEDV/LVESV should be carefully reviewed by the authors. How did you calculate LVEF? SV and strain data could be of interest.

Indeed, there was an inversion between LVEDV and LVESV in this table. Left ventricular ejection fraction was calculated by manual Simpson's biplane, realized by a certified cardiologist and followed current recommendations (Lang RM et al., 2015). The data table (data_PlosOne.xls) was modified in the supporting information.

Lang RM et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233--271

Reviewer \#2:

This paper describes a model-based approach for estimating left ventricular constructive and wasted work, and work efficiency, in patients with aortic stenosis. The model is very well suited to the question and the results are quite impressive. The main limitation is the small sample size of only 12 patients; it is therefore difficult to tell how robust the results are.

We would like to thank the reviewer and we have modified the manuscript in order to improve the article.

Concerning the small sample size, the low number of patients is due to the difficulty of measuring LV pressure in aortic stenosis because current guidelines discourage catheterization measurement techniques. In our study, LV pressure was measured because of clinically utility and all patients were informed.

1\. Line 122. The equation for calculating volume is missing a reference volume. The integral of flow can only be used to calculate a volume change, not an absolute volume.

The reviewer is right. The equation describes de flow change: . Section 1.2.3 was corrected.

\\f

2\. I assume Section 1.3 relates to the clinical data. Please make this clear at the start of this section, as it follows the model description.

Section 1.3 was modified in order to improve the description of work indices calculated from clinical and simulated data: Segmental myocardial work, as proposed by Russell et al (Russell 2013), could be calculated from 1) the clinical strain signals, deduced from TTE, and 2) the LV pressure obtained invasively by catheterization or the patient-specific pressure from the model-based approach.

Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Gjesdal O, et al. Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions. Am J Physiol Heart Circ Physiol. 2013;305:H996--H1003,.

3\. How were the S and IVR periods of the cardiac cycle defined?

The definition of S and IVR period were integrated in the legend of figure 2. S phase is defined by the time interval spanning from mitral valve closure (MVC) to aortic valve closure (AVC), whereas the IVR phase is defined between aortic valve closure and mitral valve opening (MVO).

4\. Line 170-171. "For each parameter Xj, a number r of elementary effects are calculated to estimate the mean (μ∗) and standard deviation (σ) of the effects." I don't quite follow this statement. Do the authors mean that a range of Xj values are tested and then the average effect (and SD) is taken as a measure of sensitivity? If so, how was the range of Xj values determined? And was Xj adjusted up and down? If so taking the mean would be inappropriate.

The method consists in the generation of several random trajectories through the parameter space; each trajectory being associated with an estimation of the Elementary Effects EE∗j of a parameter Xj on output Y :

where ∆ is a predefined variation. For each Xj , the mean μ∗j and standard deviation σj of r elementary effects (EEj) are calculated. A large value of μ∗j indicates a significant effect of Xi on Y , whereas a large σj value is related to either non-linear or strongly interacting variables. In order to establish a global rank of importance among parameters, we calculated the Euclidean distance Dj in the μ∗ − σ plane, from the origin to each (μ∗j , σj ) point. For each parameter Xj, the range of possible values was defined as +/- 30% of the initial value (supplementary materials).

Section 1.4.1 was modified.

5\. Figure 4 specifies a) and b), but those labels are not present. Use of (top) and (bottom) is sufficient.

Legend of figure 4 was corrected.

6\. In Section 2.3 it is unclear why R\^2 values are reported, as these are unreliable measures of agreement. E.g. High R\^2 can be obtained even when there is poor agreement, as in the two bottom left panels of Figure 7. e% values are better. I may have missed it, but what is beta? It would be helpful to remind readers of the error measures in the Figure legend.

The goodness of fit was evaluated by performing a linear regression using all the data points from the pressure waveforms, and the coefficient of determination (R2), as well as the slope (), were determined. The R2 and values were removed from figure 6 and 7 and only e% values appear in these figures. Results are presented in sections 2.3.1 and 2.3.2.

7\. In Section 2.4, it may be helpful to also explain the biases in relative terms, as I (and perhaps other readers) don't have a feel for whether -140 mmHg.% is a big or small number.

In BA analysis, mean bias were -140 mmHg.% and -12 mmHg.% respectively for GCW and GWW, which correspond to relative bias equal to 3.47 % and 2.93 % with respect to maximum GCW and GWW values. Section 2.4 was modified to explain the biases in relative terms.

8\. Line 272. "For GWE, all patients are within the 95% limits of agreement whereas, for GCW and GWW, one patient is outside". This statement is tautological, as by definition the 95% limits of agreement will always contain all or almost all of the data for a sample of this size. The authors may want to consider whether the one data point could be defined as an outlier, but this would be difficult to judge from such a small sample.

The reviewer is right. This sentence was removed from the manuscript.

9\. Line 274-276. Please check whether this text does indeed refer to the third patient in the first column of Figs 6 and 7, as the timing of the peaks for this case seem to be pretty well aligned, more so than many of the others.

In fact, there was a mistake in this sentence, as it is the third patient in the first row of Figs 6 and 7. Section 2.4 was corrected.

10\. Line 334. "we can suppose that myocardial works will be robust complementary indices independ\[e\]nt of afterload condition." This may be so, but I would suggest the authors discuss what needs to be done to establish evidence around this question.

Concerning the influence of loading conditions, it is recognized that the estimation of myocardial work provides an automatic analysis of myocardial performance that is independent of LV afterload (Galli, 2018). Because afterload data are included in the calculation of myocardial work in the form of LV pressure, the assessment of myocardial work might represent a more robust parameter with respect to the assessment of LV strain or other strain-derived parameters. The discussion section was modified.

Galli, E, Leclercq, C, Fournet, M, Hubert, A, Bernard, A, Smiseth, OA, Mabo, P, Samset, E, Hernandez, A, Donal, E (2018). Value of Myocardial Work Estimation in the Prediction of Response to Cardiac Resynchronization Therapy. J Am Soc Echocardiogr, 31, 2:220-230.

11\. Line 342. Replace "it is necessary to precise that" with "it is necessary to recognise that".

The sentence was modified in the manuscript.

12\. Line 347-350. It is surprising that filling pressure has no impact on myocardial work. Preload should have a large impact on developed pressure and cardiac output, hence I would have expected a significant sensitivity to this. Can the authors please clarify and explain this?

We agree with the reviewer. In fact, this sentence is ambiguous and the discussion section was modified. Despite the estimation of filling pressure remains imperfect, myocardial work is considered in the period from MVC to MVO, so inaccuracies before mitral valve closure and after mitral valve opening has no impact on the results.

13\. Check references. A number of references have question marks (?) in various places.

The references section was corrected.

Minor:

14\. Line 255. change "was equal 11.9% to" to "was equal to 11.9%"

15\. Line 298. Change to "the most influential"

16\. Line 326. Replace "indice" with "index"

17\. Throughout the manuscript, replace "works" with "work". E.g. "constructive and wasted myocardial work" is correct English.

We thank the reviewer for these suggestions. We have integrated all these corrections in the manuscript.
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Dear Dr Le Rolle,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

You should answer to the remaining minor comment of reviewer 1.

We would appreciate receiving your revised manuscript within 3 weeks. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Cécile Oury

Academic Editor

PLOS ONE
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Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Almost all the comments have been addressed. The remaining point that authors should, at least, acknowledge is lack of validation of the additive predictive value of the estimation of myocardial work (comment \#3). Authors provided in their response and the revised manuscript, several hypotheses that could support the usefulness of the estimation of myocardial work, but this should be validate in a cohort of AS patients. Do you have access to an external cohort of AS patients in which myocardial work could be estimated and then in which the additive predicting value could be tested? This would significantly re-inforce the message of the paper. At least, this should clearly be acknowledged by the authors.

Reviewer \#2: The authors have responded satisfactorily to all points. I congratulate the authors for an excellent paper.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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3 Feb 2020

Reviewer \#1:

Almost all the comments have been addressed. The remaining point that authors should, at least, acknowledge is lack of validation of the additive predictive value of the estimation of myocardial work (comment \#3). Authors provided in their response and the revised manuscript, several hypotheses that could support the usefulness of the estimation of myocardial work, but this should be validate in a cohort of AS patients. Do you have access to an external cohort of AS patients in which myocardial work could be estimated and then in which the additive predicting value could be tested? This would significantly re-inforce the message of the paper. At least, this should clearly be acknowledged by the authors.

We thank reviewer 1 for his comments. The objectives of this paper are 1) to propose a novel tool to estimate non-invasively myocardial work and 2) to compare model-based and invasive indices. This article does not claim to prove the additive predicting value of myocardial work estimation in aortic stenosis. The reviewer is right because this would significantly re-inforce the message of the paper. Unfortunately, we don't have currently access to any database of AS patients that incudes both echocardiographic strains and invasive ventricular pressures. We are working on the definition of a prospective study for the validation of proposed indices on AS patients and this article is the first step of our approach. We also believe that it is important to clarify the objectives of the paper and to acknowledge that our article does not claim to validate the estimation of myocardial work in a cohort of AS patients. We add several sentences in the introduction and the discussion in order to clarify these aspects.
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Dear Dr. Le Rolle,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Cécile Oury

Academic Editor

PLOS ONE
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Dear Dr. Le Rolle:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Cécile Oury

Academic Editor

PLOS ONE
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